In a randomized trial in 30 cancer patients undergoing immunotherapy with interleukin-2 (IL-2), there were significantly fewer cardiac complications in those who received 1000 mg oral L-carnitine daily in addition to IL-2 compared with those who received IL-2 alone (Lissoni 1993)
Curcumin: a review of its effects on human health
Coco M,Audrito V,Riganti C,Defilippi P,Taverna D
Molecular subtypes and variability in tumorigenesis across different subtypes of breast cancer Understanding the molecular subtypes and variability in tumorigenesis across different breast cancer subtypes allows for tailored treatments, improved patient outcomes, and the discovery of new therapeutic targets
Verma & Vasani, IJDVL 2016
This uncertainty can lead to costly delays and, more importantly, invalid research outcomes